ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,684 | 1,439 | -47,896 | -43,653 | -35,053 |
| Depreciation Amortization | 29,390 | 14,700 | 59,653 | 44,081 | 28,731 |
| Income taxes - deferred | -137 | 773 | -15,253 | -13,628 | -11,378 |
| Accounts receivable | -7,486 | -9,275 | -36,912 | -11,907 | -21,884 |
| Other Working Capital | -8,504 | -1,774 | -51,300 | -30,537 | -21,171 |
| Other Operating Activity | 21,103 | 15,561 | 60,505 | 28,841 | 30,329 |
| Operating Cash Flow | $42,050 | $21,424 | $-31,203 | $-26,803 | $-30,426 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,850 | -2,349 | -8,126 | -4,988 | -2,520 |
| Net Acquisitions | N/A | N/A | -33 | -33 | -33 |
| Purchase Sale Intangibles | -4,329 | -4 | -7,579 | -7,575 | -229 |
| Other Investing Activity | -4,329 | -4 | -7,579 | -7,575 | -229 |
| Investing Cash Flow | $-9,179 | $-2,353 | $-15,738 | $-12,596 | $-2,782 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,500 | -750 | N/A | N/A | N/A |
| Common Stock Issued | 82,001 | 157 | 1,458 | 690 | 206 |
| Common Stock Repurchased | -4,086 | -3,549 | -1,959 | -1,840 | -1,601 |
| Dividend Paid | -813 | -406 | -1,625 | -1,218 | -812 |
| Other Financing Activity | 0 | 0 | -3,000 | -2,250 | -1,500 |
| Financing Cash Flow | $75,602 | $-4,548 | $-5,126 | $-4,618 | $-3,707 |
| Beginning Cash Position | 53,234 | 53,234 | 105,301 | 105,301 | 105,301 |
| End Cash Position | 161,707 | 67,757 | 53,234 | 61,284 | 68,386 |
| Net Cash Flow | $108,473 | $14,523 | $-52,067 | $-44,017 | $-36,915 |
| Free Cash Flow | |||||
| Operating Cash Flow | 42,050 | 21,424 | -31,203 | -26,803 | -30,426 |
| Capital Expenditure | -4,850 | -2,349 | -8,876 | -5,738 | -3,270 |
| Free Cash Flow | 37,200 | 19,075 | -40,079 | -32,541 | -33,696 |